Kalbe Farma KLBF IJ -Buy- Transforming the brand
Consumer health is a very crucial division for KLBF, as it possesses the highest margin,
Consumer Durables JW SH SC 450 18th Nov, 2024
Potentially higher future growth from ex-Java expansion; Upgrade to Buy with TP of IDR1,110
In our recent report, “Finding a second wind”, we highlighted ACES' ability to overcome significant challenges after nearly 30 years of operation. We also noted the promising progress of their rebranding strategy.
Higher growth from potentially more stores opening starting next year
ACES is exploring the potential to expand its store network beyond the current 20 stores projected for 2024F (Fig. 3). This expansion is primarily focused on ex-Java regions, which could account for up to 70% of the new store openings. By lowering the population/city area criterion from 500k to 200k, ACES has identified a larger customer base in A-C income classes willing to spend in Ace stores. ACES’s number of penetrated cities increased from 51 in 2021 to 69 as of 9M24. With a 100% success rate in meeting the company’s sales/profit targets in these cities over the past 1-2 years, ACES is pursuing a more aggressive store expansion strategy, targeting approximately 100 new promising areas. Refer to our report on potential growth beyond the Java region.
This is a lucrative opportunity, as ACES can typically charge ASP 4-12% higher than stores in Jakarta to offset the increased distribution costs associated with ex-Java operations. Lower rent rates, labor costs, and competition, coupled with higher sales productivity, contribute to higher margins in ex-Java compared to Jakarta. By expanding into ex-Java, ACES could achieve a sales CAGR of 14% in 2024F-2026F, surpassing our previous forecast of 11%. This should positively impact its overall margin improvement, asset turnover, and accelerate the turnaround of ROE (Fig. 5-8). We also forecast stronger same-store sales growth (SSSG) of 8% for 24-26F, driven by new store openings and the higher potential of ex-Java markets.
Upgrade to Buy with TP of IDR1,110; +35% potential upside
We raise 2024F-2026F earnings estimates by 3-11%, primarily due to the potential for higher revenue/net profit growth from expanded store network, particularly in ex-Java. As a result, we raise our TP to IDR1,110 (from IDR935), based on an unchanged 2025F P/E of 19x (+1SD of its three-year average). We believe that by aggressively expanding into the underserved ex-Java market, ACES can further improve its ROE. We upgrade the stock to Buy. Potential downside risks include slower-than-expected ex-Java performance and increased competition. Currently, the stock trades at 14.1x P/E 2025F.
Year-end 31 Dec | FY23 | FY24F | FY25F | FY26F | |||
Currency (IDR) | Actual | Old | New | Old | New | Old | New |
Revenue (bn) | 7,612 | 8,416 | 8,533 | 9,304 | 9,694 | 10,287 | 11,090 |
Reported net profit (bn) | 764 | 843 | 865 | 974 | 1,001 | 1,090 | 1,210 |
Normalised net profit (bn) | 764 | 843 | 865 | 974 | 1,001 | 1,090 | 1,210 |
FD normalised EPS | 44.52 | 49.15 | 50.44 | 56.81 | 58.39 | 63.56 | 70.56 |
FD norm. EPS growth (%) | 14.9 | 10.4 | 13.3 | 15.6 | 15.8 | 11.9 | 20.8 |
FD normalised P/E (x) | 18.5 | – | 16.4 | – | 14.1 | – | 11.7 |
EV/EBITDA (x) | 12.4 | – | 10.9 | – | 9.5 | – | 7.5 |
Price/book (x) | 2.3 | – | 2.2 | – | 2.1 | – | 2.0 |
Dividend yield (%) | 3.8 | – | 4.0 | – | 4.6 | – | 5.3 |
ROE (%) | 12.7 | 13.4 | 13.8 | 14.8 | 15.2 | 15.7 | 17.3 |
Net debt/equity (%) | net cash | net cash | net cash | net cash | net cash | net cash | net cash |
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Up from Neutral | Buy |
Target price Increased from IDR 935 | IDR 1,110 |
Closing price 14 November 2024 | IDR 825 |
Implied upside | +34.5% |
Market Cap (USD mn) | 892.7 |
ADT (USD mn) | 2.6 |
M cap (USDmn) | 892.7 |
Free float (%) | 39.7 |
3-mth ADT (USDmn) | 2.6 |
(%) | 1M | 3M | 12M |
Absolute (IDR) | -5.2 | 9.3 | 1.9 |
Absolute (USD) | -6.9 | 8.1 | 0.8 |
Rel to Jakarta Stock Exchange Composite Index | -0.6 | 12.2 | -3.3 |
Jody Wijaya (jody.wijaya@verdhana.id),
Sandy Ham (sandy.ham@verdhana.id)
Samuel Christian (samuel.christian@verdhana.id)